Middle East and Africa Medical Cyclotron Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Type (Ring Cyclotron, Azimuthally Varying Field (AVF)); Capacity (10-12 MeV, 16-18 MeV, 19-24 MeV, 24 MeV and Above); End User (Hospitals, Specialized Clinics, Pharmaceutical Companies, Other End Users), and Country

The Middle East and Africa medical cyclotron market is expected to reach US$ 6.69 million in 2027 from US$ 5.47 million in 2019, it is estimated to grow at a CAGR of 2.6% from 2020 to 2027.

The growth of the Middle East and Africa medical cyclotron market is attributed to key driving factors such as increasing prevalence of cancer and growing inclination towards nuclear scans for accurate diagnosis. However, the high cost coupled with the procedures hinder the market growth.

A cyclotron is an electrically powered machine that produces a beam of charged particles for industrial, research, and medical purposes. In medical applications, cyclotrons have rays that are used to manufacture radioisotopes for medical imaging. Various medical cyclotrons are being used for the production of SPECT and Positron Emission Tomography (PET) isotopes used for therapeutic and other medical applications. Cyclotrons can be used in particle therapy to treat cancer with the help of ion beams that can penetrate the body and kill the tumors with radiation. Besides, proton beam therapy is used to treat tumors that do not spread in the body and, thus, do not require surgery. The prevalence of cancer is increasing every year. According to the Cancer Association of South Africa, 1,15,000 South Africans are diagnosed with cancer every year. Thus, the increasing prevalence of chronic diseases is a key factor driving the growth for the medical cyclotron market. Also, increase in development of artificial radionuclides and surge in the number of cancer treatment therapies are driving the Middle East and Africa medical cyclotrons market.

Due to the outbreak of COVID-19, the demand has to drop down due to lockdown as patients are at higher risk of exposure. In Middle East region, healthcare facilities are limiting or canceling surgeries and sometimes screenings or other treatments if it is not recognized as a life-threatening condition. Therefore, it is likely to affect the Middle East and Africa medical cyclotron market negatively.

Based on type, the Middle East and Africa medical cyclotron market is segmented into ring cyclotron, azimuthally, and varying field (AVF). The ring cyclotron segment held the largest share of the market in 2019 and is estimated to register the highest CAGR in the market during the forecast period.

The Middle East and Africa medical cyclotron market, based on capacity, is segmented into 10-12 MeV, 16-18 MeV, 19-24 MeV, and 24 MeV and above. The 16-18 MeV segment held the largest share of the market in 2019, moreover, the same segment is expected to register the highest CAGR in the market during 2020-2027.

Based on end user, the Middle East and Africa medical cyclotron market is segmented into hospitals, specialized clinics, pharmaceutical companies, and other end users. The hospitals segment held the largest share of the market in 2019. Also, the segment is anticipated to register the highest CAGR  in the market during the forecast period.

A Few of the primary and secondary sources associated with this report on the Middle East and Africa medical cyclotron market are the International Atomic Energy Agency (IAEA), Council for Science and Industrial Research (CSIR) and the Cancer Association of South Africa (CANSA).